| Karen Marlene Wagner, | |
|
2220 Canterbury Dr, Hays, KS 67601-2370 | |
| (785) 623-5850 | |
| Not Available |
| Full Name | Karen Marlene Wagner |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 2220 Canterbury Dr, Hays, Kansas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1316441991 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 11550 (Kansas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Karen Marlene Wagner, 2220 Canterbury Dr, Hays, KS 67601-2370 Ph: (785) 623-5850 | Karen Marlene Wagner, 2220 Canterbury Dr, Hays, KS 67601-2370 Ph: (785) 623-5850 |
News Archive
"Twin outbreaks of a flu-like illness and dysentery in a remote region of Papua New Guinea have killed 47 people and infected another 2,000 villagers, a senior medical official said Monday," Agence France-Presse reports. According to provincial health adviser Doctor Theo Likei, the WHO has collected and is testing samples of the virus from the "stricken villages" (8/31). Additionally, the country is experiencing a cholera outbreak - "the first time the disease has officially been confirmed in the country," the BBC reports (Mercer, 8/31).
It has been estimated that roughly 4% to 6% of child abuse victims present first to an ophthalmologist. In a case study in the April issue of the Journal of American Association of Pediatric Ophthalmology and Strabismus, doctors at the University of Washington and the Seattle Children's Hospital describe a case of a 13-month-old girl who was initially diagnosed with corneal abrasion and a mild infection. She was eventually identified as a victim of child abuse.
Alector, a privately held biotechnology company pioneering immuno-neurology, a novel therapeutic approach for the treatment of neurodegeneration, today announced the initiation of its Phase 1 trial called INFRONT, which is evaluating AL001, the company's product candidate for the treatment of a genetically-defined sub-population of patients with frontotemporal dementia.
Investigators at Hospital for Special Surgery, collaborating with researchers from other institutions, have contributed to the discovery that a gene called interferon regulator factor-8 (IRF-8) is involved in the development of diseases such as periodontitis (gum disease), rheumatoid arthritis and osteoporosis. The study, which will be published online August 30, ahead of print, in the journal Nature Medicine, could lead to new treatments in the future.
› Verified 4 days ago
Mr. Gregory E Bethel, R.PH. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2600 Vine St, Hays, KS 67601 Phone: 785-628-1767 | |
Morgan Whitmore, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4301 Vine St, Hays, KS 67601 Phone: 785-625-0037 | |
Mr. Arthur Spalsbury, PHARMACIST Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1902 Vine St, Hays, KS 67601 Phone: 785-628-6148 | |
James Meier, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2220 Canterbury Dr, Hays, KS 67601 Phone: 785-623-5850 | |
William Albert Cadoret, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2220 Canterbury Dr, Hays, KS 67601 Phone: 785-623-5000 Fax: 785-623-5854 | |
Shawn Giess, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2220 Canterbury Dr, Hays, KS 67601 Phone: 785-623-5850 | |
Dr. Jeremy Snyder, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2600 Vine St, Hays, KS 67601 Phone: 785-628-1767 |